Drug Development

Articles

Too much or too little control can actually lead to the same result.

Everybody's Got Problems

Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.

Week of May 24, 2010: Company and People Notes: Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.

Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

Week of May 17, 2010: Company and People Notes: Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) published its "Ten Principles on Counterfeit Medicines" last week to draw public attention to the issue.

IFPMA launches Ten Principles on Counterfeit Medicines

Angie Drakulich was editorial director of Pharmaceutical Technology.

Effective May 1, 2010, the US Pharmacopeia has revised its Pending Monographs Guideline to clarify that excipients are eligible for pending-monograph status and can ultimately be included in an official National Formulary (NF) monograph.

USP Opens Door to Pending Monographs for Excipients

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

In an effort to standardize quality agreements for active pharmaceutical ingredients in the drug industry, the Bulk Pharmaceuticals Task Force, an affiliate of the Society of Chemical Manufacturers and Affiliates, has developed a template to help manufacturers and customers comply with US regulatory requirements in a simplified manner.

SOCMA Issues API Quality-Agreement Template

Week Of May 10, 2010: Company And People Notes: Ariad and Merck Restructure Collaboration; Genzyme Changes Leadership; and More

The biotechnology markets in the United States, Europe, and Canada, and Australia reached aggregate profitability in 2009, according to Ernst & Young.

US, European, Canadian, and Australian Biotechnology Markets Reach Aggregate Profitability in 2009

FDA Approves AstraZeneca's and Pozen's Vimovo; Merck Announces Management Changes; And More.

Week Of May 3, 2010: Company And People Notes: FDA Approves AstraZeneca's and Pozen's Vimovo; Merck Announces Management Changes; And More.

Michelle Hoffman, editorial director of Pharmaceutical Technology.

FDA wants industry to talk to them about the science underlying process innovations-really.

Ingredients